summary
Introduced
02/05/2024
02/05/2024
In Committee
02/05/2024
02/05/2024
Crossed Over
Passed
Dead
04/08/2024
04/08/2024
Introduced Session
2024 Regular Session
Bill Summary
Repealing the requirement that each local correctional facility make available at least one formulation of each FDA-approved full opioid agonist, partial opioid agonist, and long-acting opioid antagonist used for the treatment of opioid use disorders; requiring the Maryland Secretary of Health to annually provide each county a grant equal to the costs incurred by the county for the implementation of a certain medication-assisted treatment program; and expanding the authorized uses of the Opioid Restitution Fund.
AI Summary
This bill repeals the requirement that each local correctional facility make available at least one formulation of each FDA-approved medication used for treating opioid use disorder. Instead, it requires the Maryland Secretary of Health to annually provide each county a grant equal to the costs incurred by the county for implementing a medication-assisted treatment program in its correctional facilities. The bill also expands the authorized uses of the Opioid Restitution Fund to include providing grants to counties for implementing medication-assisted treatment programs in correctional facilities.
Committee Categories
Justice
Sponsors (1)
Last Action
House Judiciary Hearing (13:00:00 3/7/2024 ) (on 03/07/2024)
Bill Topics
Health
- ‐ Drug Abuse, Treatment, and Education
Law, Crime, and Family Issues
- ‐ Prisons and Correctional Institutions
bill text
bill summary
Loading...
bill summary
Loading...
bill summary
| Document Type | Source Location | Created |
|---|---|---|
| State Bill Page | https://mgaleg.maryland.gov/mgawebsite/Legislation/Details/HB1031?ys=2024RS | 02/06/2024 |
| BillText | https://mgaleg.maryland.gov/2024RS/bills/hb/hb1031f.pdf | 02/06/2024 |
Loading...